Compare XLO & AMPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | XLO | AMPG |
|---|---|---|
| Founded | 2016 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Telecommunications Equipment |
| Sector | Health Care | Telecommunications |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 56.9M | 51.7M |
| IPO Year | 2021 | 2012 |
| Metric | XLO | AMPG |
|---|---|---|
| Price | $9.17 | $4.00 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $28.00 | $7.00 |
| AVG Volume (30 Days) | 23.3K | ★ 1.9M |
| Earning Date | 05-14-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 69.44 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $43,766,000.00 | $25,195,930.00 |
| Revenue This Year | N/A | $102.41 |
| Revenue Next Year | $168.77 | $20.00 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 589.88 | 164.99 |
| 52 Week Low | $0.46 | $1.64 |
| 52 Week High | $9.89 | $10.11 |
| Indicator | XLO | AMPG |
|---|---|---|
| Relative Strength Index (RSI) | 55.69 | 35.08 |
| Support Level | $7.47 | $2.66 |
| Resistance Level | $9.22 | $5.65 |
| Average True Range (ATR) | 0.38 | 0.49 |
| MACD | -0.00 | 0.00 |
| Stochastic Oscillator | 54.04 | 0.58 |
Xilio Therapeutics Inc is a clinical-stage biotechnology company focused on discovering and developing masked immuno-oncology (I-O) therapies to improve outcomes for people living with cancer. Leveraging its clinically validated masking technology and capabilities, the company develops I-O therapies designed to selectively activate within the tumor microenvironment to achieve durable efficacy without the severe side effects associated with systemically active I-O agents. Its integrated biology and protein engineering approach enables the design and development of potent masked biologics that are activated by tumor-specific proteases.
AmpliTech Group Inc designs, develops, engineers, and assembles micro-wave component-based amplifiers that meet individual customer specifications. It operates in two segments: the manufacturing and engineering segment. The products of the company consist of RF amplifiers & related subsystems, operating at multiple frequencies from 50kHz to 44GHz, including Low Noise Amplifiers, Medium Power Amplifiers, cryogenic amplifiers, and custom assemblies. The company also offers non-recurring engineering services on a project-by-project basis, for a predetermined fixed contractual amount, or on a time-plus-material basis. It also operates as a manufacturer, & distributor of cryogenic microwave amplifiers, RF designs, & applications for Wireless Networks & the future of Wireless Communication.